Avanza Fonder AB Makes New Investment in Axon Enterprise, Inc $AXON

Avanza Fonder AB acquired a new stake in Axon Enterprise, Inc (NASDAQ:AXON) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 18,561 shares of the biotechnology company’s stock, valued at approximately $10,541,000.

Other hedge funds also recently made changes to their positions in the company. Brighton Jones LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter worth about $480,000. NewEdge Advisors LLC grew its stake in Axon Enterprise by 41.1% in the 1st quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock valued at $1,207,000 after buying an additional 668 shares during the last quarter. Empowered Funds LLC grew its stake in Axon Enterprise by 8.4% in the 1st quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock valued at $1,067,000 after buying an additional 157 shares during the last quarter. Woodline Partners LP raised its holdings in Axon Enterprise by 40.6% in the 1st quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock valued at $3,646,000 after acquiring an additional 2,003 shares during the period. Finally, Sivia Capital Partners LLC bought a new position in Axon Enterprise in the 2nd quarter valued at about $284,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Market action: AXON closed higher in the most recent session, reflecting short‑term buying interest. Axon Enterprise (AXON) Surpasses Market Returns
• Positive Sentiment: Contract extension: Batavia extended a contract for police body‑camera data storage — a direct revenue/support win for Axon’s cloud evidence/storage business. This reinforces recurring‑revenue visibility from municipal customers. Batavia City Council OKs contract extension for police body camera data storage
• Positive Sentiment: Defense spending narrative: A commentary piece highlights Axon as a top defense/ public‑safety pick amid a large federal spending push, supporting the thesis that defense/first‑responder budgets could be a multi‑year growth tailwind. Hegseth Says It ‘Takes Money to Kill Bad Guys’…
• Positive Sentiment: New local adoption: Syracuse selected Axon as its license‑plate‑reader provider — another municipal win that supports product adoption across public‑safety portfolios. What to know about Axon, Syracuse’s newest license plate reader provider
• Positive Sentiment: Analyst/investor praise: Several investing write‑ups (including The Motley Fool and InsiderMonkeys summaries) continue to highlight Axon’s AI + hardware + subscription model as a high‑growth thesis. These narratives can support multiple expansion if execution stays strong. 2 Tech Stocks That Could Help Make You a Fortune
• Positive Sentiment: Institutional interest note: A recent investor letter/profile highlights Axon as an attractive mid‑cap growth opportunity, signaling continued institutional attention. What Makes Axon (AXON) an Attractive Opportunity?
• Neutral Sentiment: Comparative coverage: A sector comparison piece contrasts Axon with CAE; useful for valuation context but not an immediate catalyst. Contrasting Axon Enterprise and CAE
• Neutral Sentiment: Name confusion alert: AppLovin is expanding a product called “Axon AI” — this is unrelated to Axon Enterprise but can cause headlines/keyword noise; not a company catalyst. AppLovin Expands Axon AI As Investors Weigh Broader Growth Potential
• Neutral Sentiment: Short‑interest data shown for March is effectively blank/inconclusive (reported zeros); no reliable signal on bearish positioning from that data point.
• Negative Sentiment: Insider sale: A director sold ~$77k of stock — a small, single‑sale that could raise mild governance questions but is not large enough alone to indicate a change in company fundamentals. Insider Selling: Axon Enterprise Director Sells Stock
• Negative Sentiment: Local scrutiny: Opinion pieces and calls for mayoral discussion (e.g., Denver) underscore continuing political/community scrutiny over Axon contracts — a recurring risk for municipal renewals and reputation. Mike Johnston Says He’s Listening, but Will He Meet With Constituents?

Insider Activity

In other news, CAO Jennifer H. Mak sold 1,500 shares of Axon Enterprise stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $573.45, for a total value of $860,175.00. Following the transaction, the chief accounting officer owned 12,240 shares in the company, valued at approximately $7,019,028. This trade represents a 10.92% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Erika Nardini sold 198 shares of the business’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total value of $100,302.84. Following the transaction, the director directly owned 1,946 shares of the company’s stock, valued at $985,804.68. This trade represents a 9.24% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 23,855 shares of company stock valued at $13,299,928. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $507.28 on Tuesday. The firm has a 50 day moving average of $516.98 and a 200-day moving average of $597.88. Axon Enterprise, Inc has a 12 month low of $396.41 and a 12 month high of $885.91. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. The stock has a market capitalization of $40.79 billion, a PE ratio of 333.74, a PEG ratio of 10.59 and a beta of 1.46.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.55. The business had revenue of $796.72 million for the quarter, compared to analyst estimates of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The firm’s revenue for the quarter was up 38.5% on a year-over-year basis. During the same quarter last year, the business posted $2.08 EPS. On average, equities research analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on AXON. Morgan Stanley reduced their price objective on Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. Northcoast Research upgraded Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 target price on the stock in a research note on Tuesday, January 6th. UBS Group dropped their price target on Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating for the company in a report on Wednesday, February 25th. Barclays reduced their price target on Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Finally, Wall Street Zen raised Axon Enterprise from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $762.93.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.